Skip to navigation Skip to content

Growth hormone deficiency – childhood onset or late onset Program in Pharmaceutical Benefits Scheme (PBS) 012-18112104

Expand/Collapse all sectionsExpand all



Growth hormone deficiency - childhood onset or late onset restriction and item codes

Do not share this attachment externally. See Freedom of information - Information Publication Scheme.

https://ourblueprint.internal.dept.local/content/images/icon-hidden-attachment.png|A linked attachment is available for staff only (i.e. under IPS/FOI)PBS growth hormone deficiency - childhood onset or late onset restriction and item codes

Contact details

PBS Complex Drugs Programs

Forms

Growth hormone deficiency - late onset initial authority application form (PB248)

Growth hormone deficiency - childhood onset initial authority application form (PB288)

Services Australia website

Growth hormone deficiency - childhood onset or late onset

External websites

PBS schedule for somatropin

FAQs from Service Officers

Table 1: see Table 2 in Processing Complex Authority Required Listings for FAQs about all Complex programs.

Item

Description

1

Does a patient have to be over 18 to be approved for growth hormone?

No. The childhood-onset restrictions only require the patient to have reached skeletal maturity, not to be 18 years or older. For the late-onset indication, the patient must be 18 years or older.

2

How does a prescriber write a prescription for growth hormone?

The Authority request must be written for a quantity sufficient for one month's treatment, with up to 5 repeats. Only some brands of growth hormone are listed for these patients. Refer to a PA if unsure.